Cardiff Oncology Inc
CRDF
Market Cap$176.96M
Close$
$0.61
77.7% downside
Current Fair Value
77.7% downsideOvervalued by 77.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $176.96 Million |
|---|---|
| Enterprise Value | $127.01 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.95 |
| Beta | 1.8 |
| Outstanding Shares | 55,242,721 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -3.23 |
|---|---|
| PEG | -14.78 |
| Price to Sales | - |
| Price to Book Ratio | 2.75 |
| Enterprise Value to Revenue | 184.34 |
| Enterprise Value to EBIT | -2.74 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Cardiff Oncology Inc
CEO: Mark Erlander